| Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia–reperfusion model FR Formiga, B Pelacho, E Garbayo, G Abizanda, JJ Gavira, ... Journal of Controlled Release 147 (1), 30-37, 2010 | 263 | 2010 |
| Effective GDNF brain delivery using microspheres—a promising strategy for Parkinson's disease E Garbayo, CN Montero-Menei, E Ansorena, JL Lanciego, MS Aymerich, ... Journal of Controlled Release 135 (2), 119-126, 2009 | 183 | 2009 |
| Advances in Parkinson’s disease: 200 years later NLG Del Rey, A Quiroga-Varela, E Garbayo, I Carballo-Carbajal, ... Frontiers in neuroanatomy 12, 113, 2018 | 173 | 2018 |
| Heart regeneration after myocardial infarction using synthetic biomaterials S Pascual-Gil, E Garbayo, P Díaz-Herráez, F Prosper, MJ Blanco-Prieto Journal of Controlled Release 203, 23-38, 2015 | 164 | 2015 |
| Hydrogel based approaches for cardiac tissue engineering L Saludas, S Pascual-Gil, F Prósper, E Garbayo, M Blanco-Prieto International journal of pharmaceutics 523 (2), 454-475, 2017 | 152 | 2017 |
| The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats GJR Delcroix, E Garbayo, L Sindji, O Thomas, C Vanpouille-Box, ... Biomaterials 32 (6), 1560-1573, 2011 | 151 | 2011 |
| Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through … FR Formiga, B Pelacho, E Garbayo, I Imbuluzqueta, P Díaz-Herráez, ... Journal of Controlled Release 173, 132-139, 2014 | 149 | 2014 |
| Nanomedicine and drug delivery systems in cancer and regenerative medicine E Garbayo, S Pascual‐Gil, C Rodríguez‐Nogales, L Saludas, ... Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 12 (5 …, 2020 | 128 | 2020 |
| EF1α and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells KM Curtis, LA Gomez, C Rios, E Garbayo, AP Raval, MA Perez-Pinzon, ... BMC molecular biology 11, 1-15, 2010 | 123 | 2010 |
| Drug development in Parkinson's disease: from emerging molecules to innovative drug delivery systems E Garbayo, E Ansorena, MJ Blanco-Prieto Maturitas 76 (3), 272-278, 2013 | 110 | 2013 |
| Organotypic cultures as tools for optimizing central nervous system cell therapies N Daviaud, E Garbayo, PC Schiller, M Perez-Pinzon, CN Montero-Menei Experimental neurology 248, 429-440, 2013 | 101 | 2013 |
| Micro-and nanotechnology approaches to improve Parkinson's disease therapy PV Torres-Ortega, L Saludas, AS Hanafy, E Garbayo, MJ Blanco-Prieto Journal of controlled release 295, 201-213, 2019 | 79 | 2019 |
| Catheter-based intramyocardial injection of FGF1 or NRG1-loaded MPs improves cardiac function in a preclinical model of ischemia-reperfusion E Garbayo, JJ Gavira, MG de Yebenes, B Pelacho, G Abizanda, H Lana, ... Scientific Reports 6 (1), 25932, 2016 | 72 | 2016 |
| Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres E Garbayo, E Ansorena, JL Lanciego, MS Aymerich, MJ Blanco-Prieto European journal of pharmaceutics and biopharmaceutics 69 (3), 844-851, 2008 | 69 | 2008 |
| Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys E Garbayo, E Ansorena, H Lana, M del Mar Carmona-Abellan, I Marcilla, ... Biomaterials 110, 11-23, 2016 | 64 | 2016 |
| Brain aging and Parkinson’s disease: New therapeutic approaches using drug delivery systems C Rodríguez-Nogales, E Garbayo, MM Carmona-Abellán, MR Luquin, ... Maturitas 84, 25-31, 2016 | 64 | 2016 |
| Neuroprotective properties of marrow‐isolated adult multilineage‐inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic … E Garbayo, AP Raval, KM Curtis, D Della‐Morte, LA Gomez, G D’Ippolito, ... Journal of neurochemistry 119 (5), 972-988, 2011 | 60 | 2011 |
| Lipid nanoparticles for siRNA delivery in cancer treatment SH El Moukhtari, E Garbayo, A Amundarain, S Pascual-Gil, ... Journal of Controlled Release 361, 130-146, 2023 | 59 | 2023 |
| Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease E Garbayo, E Ansorena, JL Lanciego, MJ Blanco‐Prieto, MS Aymerich Movement disorders 26 (10), 1943-1947, 2011 | 59 | 2011 |
| Cytokine-loaded PLGA and PEG-PLGA microparticles showed similar heart regeneration in a rat myocardial infarction model S Pascual-Gil, T Simón-Yarza, E Garbayo, F Prósper, MJ Blanco-Prieto International journal of pharmaceutics 523 (2), 531-533, 2017 | 57 | 2017 |
